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Object: to evaluate the influence of diabetes mellitus on the therapeutic indications and the one-month results in patients
with occlusive disease of the aorta and/or lower limbs arteries.
Material: a retrospective study of fully computerised data of 1003 patients (753 men, 250 women) admitted consecutively
to our vascular surgery unit over a 5-year period (1992–1996). Of the total, 169 were diabetics (group I) and 834 were
non-diabetics (group II). Sixty-two per cent of patients in group I vs. 40% in group II presented with critical ischaemia
or trophic changes (p<0.001).
Results: 15.4% of patients in group I vs. 4.1% in group II had primary amputation because of irreversible ischaemia or
because arterial reconstruction was impossible. Of those who underwent revascularisation, 80% were infrainguinal in
group I vs. 50% in group II. Forty-five per cent of patients in group I and 37% in group II had a percutaneous
transluminal angioplasty (PTA) and approximately 3% in both groups had a combination of the two techniques. At one
month, patients alive without major amputation numbered 64.4% in group I vs. 93.6% in group II, patients alive with
major amputation numbered 26.6% in group I vs. 5.5% in group II, and mortality rates were 8.9% in group I vs. 0.8%
in group II (p<0.001).
Conclusions: the 5-times higher amputation and 10-times higher mortality rates for diabetics compared to non-diabetics
call for better collaborative management of diabetics between general practitioners, vascular surgeons, diabetologists and
cardiologists. PTA with a 90% initial success rate is indicated for short lesions even in the presence of limited gangrene.
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Introduction Material and Methods
Of the 1003 patients (753 men, 250 women) admittedThe prognosis of occlusive arterial disease is con-
to our vascular surgery unit for occlusive disease ofsiderably worse in diabetics than in non-diabetics.
the aorta and/or lower limbs arteries between JanuaryThe proportion of patients suitable for intervention is
1992 and December 1996, 16.9% were diabetics (grouplower, failure after revascularisation is often caused
I, n=169) and 83.1% were non-diabetics (group II, n=by sepsis, and perioperative mortality is increased.
834). Diabetics were defined as patients on an anti-This poor outcome is explained by the distal location
diabetic treatment or with a blood-sugar level higherof the arterial lesions, and the frequent association
than 140 mg/100 ml on admission. Forty-eight (28.4%)with diabetic microangiopathy, nephropathy and
had type I diabetes and 121 (71.6%) type II. The mediancardiomyopathy. Although many studies deal with
ages of diabetics and non-diabetics were similar (68epidemiology and severity of vascular disease in dia-
and 67 years, respectively). The proportion of womenbetic patients,1–3 only one paper was found dealing
was 32.5% in group I, significantly higher than thewith the influence of diabetes on the type of treatment
23.4% in group II (p<0.02). In this study, the overalland the early results. However, it did not discuss the
results were not statistically different between the twochoice between conventional surgery and per-
sexes in either group and, therefore, men and womencutaneous transluminal angioplasty (PTA).4 The pur-
were not studied separately. Other risk factors suchpose of this retrospective study was to assess the
as smoking habits were not studied because of theinfluence of diabetes on the current practice of a
difficulties of classification. In group I, 76 (45%) of thevascular unit and the early results of intervention.
patients presented with trophic changes vs. 141 (17%)
in group II (p<0.001). Overall 105 (62%) of patients in
group I and 336 (40%) in group II presented with* Please address all correspondence to: D. Mellie`re, Unit of Vascular
Surgery, Henri Mondor Hospital, 94010 Creteil, France. critical ischaemia or trophic changes.
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Table 1. Global results at one month whatever the therapeuticPrimary major amputation was performed in 26
option used.*patients in group I (15.4%) vs. 34 in group II (4.1%)
Diabetes Present Absentbecause of irreversible ischaemia or unsuitable arteries
for arterial reconstruction. All the other patients, in-
n % n %cluding those initially managed with a distal am-
A without amputation 91 53.8 766 91.8putation, were assessed as to the choice of arterial
A+distal amputation 18 10.6 15 1.8treatment. The team were experienced in both PTA
A+below-knee amputation 21 12.4 19 2.3and conventional surgery and so the method which A+above-knee amputation 24 14.2 27 3.2
Deceased 15 8.9 7 0.8was thought to offer the best long-term performance
Total 169 100 834 100with the lowest perioperative risk, considering the
symptoms, arterial lesions and co-morbidities, was
A=Alive.
chosen for each patient. The indications did not alter * p<0.001 for amputations in survivors and p<0.001 in deceased.
during the 5-year period and were not influenced by
the presence of diabetes. In group I, 151 patients had
Table 2. Results at one month after conventional treatment (in-
an arterial reconstruction, five had a sympathectomy, cluding combination with PTA).*
and four were treated pharmacologically. In group II,
Diabetes Present Absent788 patients had an arterial reconstruction, 36 had
a sympathectomy and 25 were treated pharmaco- n % n %
logically (in both groups the proportions undergoing
A without amputation 51 61.4 469 94.4surgical sympathectomy and chemical sympathectomy
A+distal amputation 6 7.2 4 0.8
was virtually the same). A+below-knee amputation 9 10.8 5 1
A+above-knee amputation 8 9.6 11 2.2One patient in group I and 32 patients in group II
Deceased 9 10.8 4 0.8had simultaneous bilateral reconstructions. Diabetic
Total 83 100 497 100patients were managed in close liaison with dia-
betologists; during critical periods, all the patients * Fisher test=p<0.001 for “deceased” vs. “survival”.
were converted to insulin and the principles of the
European consensus were applied.5 Local thrombolysis
Table 3. Results at one month after PTA.*
was not analysed separately because it was always
Diabetes Present Absentcombined with conventional surgery or PTA. All pro-
cedures and results were prospectively entered into a
n % n %
database at discharge and at outpatient clinics one
A without amputation 59 86.8 281 96.6month later. The treatment recorded was the most
A+distal amputation 2 2.9 2 0.7invasive, i.e. when a patient was treated first medically
A+below-knee amputation 2 2.9 4 1.4
and then surgically, the second option was recorded. A+above-knee amputation 4 5.9 2 0.7
Deceased 1 1.5 2 0.7Statistical tests included the Chi-squared test with
Total 68 100 291 100the Yates correction if necessary and Fisher’s test for
small samples. * p<0.05 for major amputations.
without major amputation vs. 91.8% of group II
(p<0.001), and 29.2% of group I patients had a majorResults
amputation vs. 5.6% of group II. The mortality rate in
diabetics was approximately 10 times higher than inInfrainguinal arterial revascularisation was performed
in 121 (80%) of group I and 395 (50%) of group non-diabetics: 8.9% vs. 0.8% (p<0.001) and the lower
limb amputation was approximately five times higherII patients (p<0.001). In both groups, most arterial
revascularisation was performed by conventional sur- than in non-diabetics (p<0.001) (Table 1). Mortality and
limb salvage rates were not related to sex in eithergery. Sixty-eight (45%) of group I and 291 (37%) of
group II patients were treated by PTA and about groups.
The main differences in mortality and amputation4% in both groups had a combination of the two
techniques. Differences in therapeutic options between rate between the groups occurred after conventional
surgery (Table 2), whilst, after PTA, the differences ingroups I and II were not statistically significant. Con-
versely, early results, whatever treatment was used, amputation and mortality rates were far less significant
(Table 3). Early results of PTA according to the clinicalwere significantly different in the two groups: at one
month only 53.8% of group I patients were alive stage on admission showed that in both groups (Tables
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Table 4. Early results of PTA according to symptoms in diabetics may be compared with a multicentre English study
(n=68).
based on 679 limbs with critical ischaemia which in-
Stage* II III IV Acute cluded 30% of diabetics.4 The proportion of women
ischaemia affected was similar in diabetics and non-diabetics,
contrary to our study where the proportion of womenA without amputation 42 5 12 0
A+distal amputation 0 1 0 1 was higher in diabetics. The mean age was 71 years,
A+below-knee amputation 0 1 1 0 similar to this series and, as in this study, the numberA+above-knee amputation 0 2 2 0
of attempts at revascularisation was lower in diabeticsDeceased 0 0 1 0
than in non-diabetics (62.3% vs. 72%) and, at discharge,Total 42 9 16 1
the amputation rate was higher in diabetics (22.5% vs.
* Fontaine classification. 12.8%). However, this last difference was smaller than
in the present series, where diabetes increased the
Table 5. Early results of PTA according to symptoms in non-
amputation risk by a factor of five (26.6% vs. 5.5%).diabetics (n=291).
The mortality rates were similar in both groups (15%
Stage* II III IV Acute vs. 12%), contrary to the present series where the
ischaemia
mortality rates were lower than in the English study
A without amputation 244 14 17 6 but 10 times higher in diabetics than in non-diabetics
A+distal amputation 1 1 0 0 (9% vs. 1%).
A+below-knee amputation 0 1 3 0
In the rest of the literature, the influence of diabetesA+above-knee amputation 0 0 2 0
Deceased 0 0 2 0 on amputation and mortality rates is controversial.4,6–8
Total 245 16 24 6 The higher mortality of diabetics is partially explained
by the larger proportion of patients unsuitable for* Fontaine classification.
arterial reconstruction.9 In this study, mortality was
mainly due to infections and cardiac complications. InTable 6. Cause of deaths.
the Framingham study, the risk of cardiac insufficiency
Diabetes Present Absent in diabetic patients with intermittent claudication was
approximately three times higher than in patientsCardiopathy 5 1
Multiorgan failure 4 3 suffering from only one of these problems.1 The in-
Pulmonary insufficiency 1 1 fluence of sex is also controversial.7,10,11 However, sex
Sepsis 3 0
did not influence early results in this study.Miscellaneous 2 2
Can the results in diabetic patients be improved?Total 15 7
This study confirms that the management of vascular
problems in diabetic patients is not very different
4 and 5) PTA was useful in a large proportion of cases, from that in non-diabetics.12 In patients with critical
including diabetics with ischaemic trophic changes. ischaemia, long lesions should be treated with bypass
The outcome for the non-revascularised patients surgery.5 The influence of diabetes on the outcome
was as follows: in the patients treated by sym- of infrapopliteal bypasses is controversial: absent for
pathectomy (n=5 in group I, n=36 in group II), there some authors,13,14 adverse for others,15 positive for
was no death or amputation. In the patients treated Rutherford et al.16 Many studies have shown the
medically (association of heparin and vasoactive benefits of distal bypasses in these patients. Sayers et
drugs), all those in group I died (n=4) and all those al.17 found primary, assisted primary and secondary
in group II were alive without amputation (n=25). Of patency rates at three years of 29, 57, 64% respectively
the patients who underwent a primary amputation, with a limb salvage rate of 67% in all patients (diabetics
15.4% in group I vs. 4% in group II died. The causes and non-diabetics) and a perioperative mortality rate
of death in both groups are summarised in Table 6. two times higher in diabetics (18% vs. 9%). Plecha et
al.18 found primary and secondary patency rates at
three years higher in diabetics than in non-diabetics
(74% and 86% vs. 27% and 50%) with a perioperativeDiscussion
mortality rate of 5% in both groups. This author at-
tributed the success in diabetics to the young age ofOur results confirm the fact that diabetes is associated
the patients, the absence of a previous operation andwith a more widespread atherothrombotic disease and
the shortness of the lesions. Tannenbaum et al.19 re-that the prognosis is worsened by microangiopathy,
nephropathy and cardiomyopathy. The present series ported, three years after venous bypass to the dorsal
Eur J Vasc Endovasc Surg Vol 17, May 1999
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patients: results of a national survey. Diabetic Medicine 1996; 13:pedal artery in diabetics presenting with septic feet,
726–728.
91.8% primary patency, 97.8% limb salvage and 83% 5 Tooke JE. European consensus document on critical limb isch-
aemia: implications for diabetes. Diabetic Medicine 1990; 7: 544–survival rates with a perioperative mortality of 1.8%.
546.However, patency rates 10% lower have been reported
6 McDaniel MD, Cronenwett JL. Donne´es de base concernant
by another team.20 These distal bypasses are perhaps l’histoire naturelle de la claudication intermittente. Ann Chir
Vasc 1989; 3: 273–277.too seldom performed: 1% in the English multicentre
7 Luther M, Lepa¨ntalo M. Femorotibial reconstructions forstudy4 and 0.7% in this study. They require good
chronic critical leg ischaemia: influence on outcome by diabetes,
angiograms showing the foot arteries and skilled sur- gender and age. Eur J Endovasc Surg 1997; 13: 569–577.
8 Sayers RD, Thompson MM, Hartshorne HT, Budd JS, Bellgeons.21 The decision to perform such a distal bypass
PRF. Treatment and outcome of severe lower-limb ischaemia. Brshould be taken early when any sepsis has been erad- J Surg 1994; 81: 521–523.
icated by debridements and there is no evidence of 9 Lepa¨ntalo M, Ma¨tzke S. Outcome of unreconstructed chronic
critical leg ischaemia. Eur J Endovasc Surg 1996; 11: 153–157.wound healing.
10 Harris J, Taylor M, Moneta GL, Porter JM et al. Outcome ofPTA entered the current therapeutic arsenal two infrainguinal arterial reconstruction in women. J Vasc Surg 1993;
decades ago. In 1987, 86% early successes were re- 18: 627–636.
11 Magnant JG, Cronenwett JL, Walsh BD et al. Surgical treat-ported in diabetics as well as in non-diabetics22 but
ment of infrainguinal arterial occlusive disease in women. J Vascrecurrences at five years were most frequent in dia- Surg 1993; 17: 67–78.
betics.23 More recent studies have confirmed the feas- 12 Benhamou AC, Dadon M, Emmerich J et al. Arteriopathy of
the lower limb in the diabetic patient. Recommendations ofibility and the interest of PTA in diabetics,24 including
ALFEDIAM. Diabetes Metabolism 1997; 6: 541–548.the infrapopliteal arteries, even if the long-term results 13 Dalsing MC, White JV, Yao JST et al. Infrapopliteal bypass for
are not as good as in non-diabetics.25,26 In this study, established gangrene of the forefoot or toes. J Vasc Surg 1985; 2:
669–677.PTA represented 45% of revascularisation procedures
14 Ricco JB, Flinn WR, McDaniel MD, Yao JST, Bergan JJ.in diabetics presenting with occlusive disease vs. 36.9% Objective analysis of factors contributing to failure of tibial
bypass grafts. World J Surg 1983; 7: 347–352.in non-diabetics. The early results showed that PTA
15 Sipponen J, Ala-Kulju K, Ketonen P et al. Femorotibial bypasshelped to preserve the foot in 89.7% of all diabetics
grafting for lower limb ischaemia. Int Angiol 1989; 8: 65–69.
and 75% of those presenting with trophic changes, 16 Rutherford RB, Jones DN, Bergentz SE et al. Factors affecting
the patency of infrainguinal bypass. J Vasc Surg 1988; 8: 236–246.with a low perioperative mortality. In another study,
17 Sayers RD, Thompson MM, London NJM et al. Selection ofwe have observed a three-year assisted primary pat-
patients with critical limb ischaemia for femorodistal vein bypass.
ency after PTA in patients with trophic changes of Eur J Vasc Surg 1993; 7: 291–297.
18 Plecha E, Lee C, Hye RJ. Facteurs influenc¸ant les re´sultats des88% in diabetics and 80% in non-diabetics (un-
pontages juxta-malle´olaires. Ann Chir Vasc 1996; 10: 356–360.published data). 19 Tannenbaum GA, Pomposelli FB, Marcaccio EJ et al. Safety
In conclusion, the higher mortality of diabetic of vein bypass grafting to the dorsal pedal artery in diabetic
patients with foot infections. J Vasc Surg 1992; 15: 928–990.patients should not deter vascular surgeons from at-
20 Davidson JT, Callis JT. Arterial reconstructions of vessels intempting revascularisation by conventional surgery, the foot and ankle. Ann Surg 1993; 217: 669–710.
PTA or a combination.27 Better control of blood sugar 21 Pomposelli FB, Jepsen SJ, Gibbons GW et al. Efficacy of the
dorsal pedal bypass for limb salvage in diabetic patients: short-levels and aggressive treatment of cardiac and renal
term observations. J Vasc Surg 1990; 11: 745–752.disease may help to improve the results. 22 Burnett JR, Walsh JA, Howard PR et al. Transluminal balloon
angioplasty in diabetic peripheral vascular disease. Aust NZ J
Surg 1987; 57: 307–309.
23 Roocke TW, Stanson AW, Johnson CM et al. Percutaneous
transluminal angioplasty in the lower extremities: a 5-year ex-
perience. Mayo Clin Proc 1987; 62: 85–91.References 24 Faglia E, Favales F, Quarantielo A et al. Feasibility and
effectiveness of peripheral percutaneous transluminal balloon
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